Grand Hôpital de Charleroi — Charleroi

Public research footprint of Grand Hôpital de Charleroi, compiled from the ClinicalTrials.gov public registry.

129

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung (NSCLC) · Non-Small Cell Lung Cancer Metastatic · HR+/HER2- Breast Cancer · Platinum-resistant Ovarian Cancer

Recently updated registry entries

NCT07106632 — Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent… (Recruiting)
NCT06252649 — Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… (Recruiting)
NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Grand Hôpital de Charleroi?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.